Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

eHealth in Treatment of Gestational Diabetes - eMOM GDM -Study (Phase 2)

NCT04714762 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT04714762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
eHealth in Treatment of Gestational Diabetes - eMOM GDM -Study (Phase 2)
Lead sponsor
Helsinki University Central Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 10, 2021
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes, mobile application